《心血管毒理學(xué)》是唯一一本致力于發(fā)表心血管疾病分子治療的當(dāng)代期刊，及時(shí)的評(píng)論，實(shí)驗(yàn)和臨床數(shù)據(jù)。CT發(fā)表的論文將闡明環(huán)境毒物對(duì)心血管系統(tǒng)的影響、分子機(jī)制和信號(hào)通路。還包括新的心血管藥物的有害作用，以及非心血管藥物、抗癌化療和基因治療的心血管作用。此外，心血管毒理學(xué)報(bào)告新的心血管和非心血管藥物的安全性和毒理學(xué)數(shù)據(jù)。這是一份獨(dú)特的雜志，在其中，這些數(shù)據(jù)可以單獨(dú)審查的效力。

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.